Aim: Modern tool designs frequently employ molecular docking to anticipate small molecules’ binding orientation and better comprehend drug-receptor interactions. Carvone’s molecular docking analysis against sodium channels and GABA-AT is part of this research investigation.
 Introduction: Carvone’s molecular docking analysis against sodium channels and GABA-AT is part of this research investigation. The biological significance of carvone has been demonstrated to include anti-epileptic, anti-fungal, anti-inflammatory, anti-cancer, and antioxidant effects. In modern drug design, molecular docking is commonly used to get an understanding of drug-receptor interaction carried out an in-silico evaluation of derivatives of carvone.
 Methodology: ChemDraw 2D (15.1) software is used to draw the ligands, ChemDraw-3D is utilized to decrease energy consumption, chimera is used to produce the protein, and Auto Dock 4.0 was used to examine the binding score. To determine whether it would cross to BBB+/BBB- or not, cheminformatics and fingerprint analysis were done using Molinspiration and Adaboost with SVM.
 Result: Comparable metrics for newly created carvone derivatives included potential energy, docking score, glide score, and highest docking score. Compounds with docking scores of (-8.39, -5.06, -4.00 kcal/mol). The conformers at the active site are shown and predicted using Discovery Studio Visualizer.
 Conclusion: The results of the molecular docking study showed that compound1 has a high affinity for the active pocket and a low binding energy, which made them potentially useful as an anti-convulsant.